,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-10-08 06:31:00,"Chicago, IL - October 8, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.018444277346134186,0.0087295426055789,0.9728261828422546,neutral,0.009714734740555286
1,2018-10-08 06:31:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2018-10-08 06:31:00,"Stocks recently featured in the blog include Home Depot HD , Bristol-Myers BMY , Costco COST , Ecolab ECL and Ameriprise Financial AMP .",0.023398542776703835,0.008910691365599632,0.9676907062530518,neutral,0.014487851411104202
3,2018-10-08 06:31:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
4,2018-10-08 06:31:00,Get #1Stock of the Day pick for free.,0.0864095613360405,0.03249066323041916,0.8810997605323792,neutral,0.05391889810562134
5,2018-10-08 06:31:00,"Here are highlights from Friday's Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.2284756302833557,0.009567669592797756,0.7619567513465881,neutral,0.21890796720981598
6,2018-10-08 06:31:00,"Today's Research Daily features new research reports on 16 major stocks, including Home Depot, Bristol-Myers and Costco.",0.03646446764469147,0.00918640661984682,0.954349160194397,neutral,0.02727806195616722
7,2018-10-08 06:31:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
8,2018-10-08 06:31:00,"You can see all of today's research reports here >>>

Buy-ranked Home Depot 's shares have gained +19.9% over the past year, marginally underperforming the Zacks Retail Building Products industry's +20.9% increase.",0.9228290915489197,0.056695666164159775,0.020475244149565697,positive,0.866133451461792
9,2018-10-08 06:31:00,"The Zacks analyst thinks that this performance is attributable to its five-year long trend of beating earnings estimates, which continued in second-quarter fiscal 2018.",0.8927931189537048,0.03878362104296684,0.06842324137687683,positive,0.8540095090866089
10,2018-10-08 06:31:00,"Moreover, sales reverted to a positive surprise trend after a miss in the last-reported quarter.",0.835457980632782,0.07232441008090973,0.0922175794839859,positive,0.7631335854530334
11,2018-10-08 06:31:00,Results gained from a rebound in the seasonal business that impacted sales in the fiscal first quarter and the solid execution.,0.951236367225647,0.021720444783568382,0.0270431786775589,positive,0.9295158982276917
12,2018-10-08 06:31:00,"Further, its relentless focus on affording innovative products, boosting interconnected customer experience and driving productivity seems to be paying off.",0.9182772040367126,0.0140379061922431,0.0676848292350769,positive,0.904239296913147
13,2018-10-08 06:31:00,A steady housing market recovery and strong customer demand also remain tailwinds.,0.2597901523113251,0.6092572212219238,0.1309526115655899,negative,-0.34946706891059875
14,2018-10-08 06:31:00,"Backed by the solid performance in the first half of fiscal 2018, the company raised the earnings and sales forecast for fiscal 2018.",0.911295473575592,0.018950916826725006,0.06975354999303818,positive,0.8923445343971252
15,2018-10-08 06:31:00,"However, commodity cost inflation in various categories, including rising raw material and transportation costs as well as recently enacted tariffs are likely to pressure margins.",0.041271477937698364,0.680564284324646,0.27816423773765564,negative,-0.63929283618927
16,2018-10-08 06:31:00,(You can read the full research report on Home Depot here >>> ).,0.012610534206032753,0.013505421578884125,0.973884105682373,neutral,-0.0008948873728513718
17,2018-10-08 06:31:00,"Shares of Buy-ranked Bristol-Myers have underperformed the Zacks Large Cap Pharmaceuticals industry year to date, increasing +1.8% vs. a gain of +7.2%.",0.8323633670806885,0.13853347301483154,0.029103102162480354,positive,0.6938298940658569
18,2018-10-08 06:31:00,"However, Bristol-Myers' blockbuster immuno-oncology drug Opdivo continues to maintain momentum.",0.905296802520752,0.014655119739472866,0.0800480991601944,positive,0.8906416893005371
19,2018-10-08 06:31:00,"Opdivo's performance is being boosted by the uptake in new indications, first line renal cell and adjuvant melanoma.",0.9500636458396912,0.015041302889585495,0.03489494323730469,positive,0.9350223541259766
20,2018-10-08 06:31:00,Several label expansion applications for Opdivo are under review in the United States and Europe.,0.06877119839191437,0.008834661915898323,0.9223940968513489,neutral,0.059936538338661194
21,2018-10-08 06:31:00,The drug was recently approved for small cell lung cancer in the United States and melanoma in Europe.,0.6385687589645386,0.012296169996261597,0.34913501143455505,positive,0.6262725591659546
22,2018-10-08 06:31:00,Potential approval in other indications will further boost the prospects of this blockbuster drug.,0.9477016925811768,0.01676386035978794,0.03553437441587448,positive,0.9309378266334534
23,2018-10-08 06:31:00,Eliquis is expected to drive further growth in 2018 driven by increases in market share in the novel oral anticoagulant (NOAC) market.,0.9292738437652588,0.012958596460521221,0.057767510414123535,positive,0.9163152575492859
24,2018-10-08 06:31:00,The label expansion of other drugs like Sprycel and Empliciti also bode well for the company.,0.9342460036277771,0.013918817043304443,0.05183522030711174,positive,0.9203271865844727
25,2018-10-08 06:31:00,"However, pricing concerns, stiff competition in the immuno-oncology space are expected to remain an overhang.",0.14041945338249207,0.379086971282959,0.48049360513687134,neutral,-0.23866751790046692
26,2018-10-08 06:31:00,(You can read the full research report on Bristol-Myers here >>> ).,0.013764891773462296,0.012010612525045872,0.9742245078086853,neutral,0.0017542792484164238
27,2018-10-08 06:31:00,"Buy-ranked Costco 's shares have outperformed the Zacks Discount Retail industry over the past six months, gaining +25.9% versus the industry's +19.2% increase.",0.9296433329582214,0.051515474915504456,0.018841218203306198,positive,0.8781278729438782
28,2018-10-08 06:31:00,Costco continues to be one of the dominant retail wholesalers based on the breadth and quality of merchandise offered.,0.4792155921459198,0.009499073959887028,0.5112853050231934,neutral,0.46971651911735535
29,2018-10-08 06:31:00,The Zacks analyst thinks the stock has been gaining from sturdy comps performance and upbeat results.,0.9537553191184998,0.021354783326387405,0.024889828637242317,positive,0.9324005246162415
30,2018-10-08 06:31:00,"Notably, comps for fourth-quarter fiscal 2018 advanced 9.5% year over year, while revenues improved 5%.",0.9530531764030457,0.02152896299958229,0.025417862460017204,positive,0.9315242171287537
31,2018-10-08 06:31:00,"In fact, this marks the company's sixth consecutive revenue beat.",0.9312755465507507,0.027398882433772087,0.04132557287812233,positive,0.9038766622543335
32,2018-10-08 06:31:00,"Undoubtedly, the robust performance indicates that the company's growth efforts have been fueling traffic across both the online and brick-and-mortar platforms.",0.9388510584831238,0.016079258173704147,0.045069620013237,positive,0.9227718114852905
33,2018-10-08 06:31:00,"Moreover, the company is augmenting merchandise offerings and delivery services to further boost e-commerce sales.",0.9508553743362427,0.015686271712183952,0.03345830738544464,positive,0.9351691007614136
34,2018-10-08 06:31:00,"However, lower core merchandise margins have been weighing on Costco's gross margin.",0.023869264870882034,0.9573349356651306,0.01879584975540638,negative,-0.9334656596183777
35,2018-10-08 06:31:00,"Further, rising SG&A expenses, stiff competition and unfavorable currency changes continue to pose threats.",0.04806667938828468,0.8391444087028503,0.11278897523880005,negative,-0.791077733039856
36,2018-10-08 06:31:00,(You can read the full research report on Costco here >>> ).,0.011449351906776428,0.012908922508358955,0.9756417870521545,neutral,-0.0014595706015825272
37,2018-10-08 06:31:00,Other noteworthy reports we are featuring today include Ecolab and Ameriprise Financial.,0.025419173762202263,0.0064112283289432526,0.968169629573822,neutral,0.01900794543325901
38,2018-10-08 06:31:00,"It's hard to believe, even for us at Zacks.",0.08736173063516617,0.254048228263855,0.6585900187492371,neutral,-0.1666865050792694
39,2018-10-08 06:31:00,"But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.",0.5075593590736389,0.04700726270675659,0.4454334080219269,positive,0.4605520963668823
40,2018-10-08 06:31:00,And this outperformance has not just been a recent phenomenon.,0.07535909861326218,0.015217346139252186,0.9094235301017761,neutral,0.060141753405332565
41,2018-10-08 06:31:00,Over the years it has been remarkably consistent.,0.6927107572555542,0.013971779495477676,0.29331743717193604,positive,0.6787389516830444
42,2018-10-08 06:31:00,"From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over.",0.7464389204978943,0.10755439102649689,0.14600670337677002,positive,0.6388845443725586
43,2018-10-08 06:31:00,Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.,0.5744941830635071,0.01052891369909048,0.41497692465782166,positive,0.5639652609825134
44,2018-10-08 06:31:00,Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.,0.06386703997850418,0.004654404241591692,0.9314785599708557,neutral,0.059212636202573776
45,2018-10-08 06:31:00,"Continuous coverage is provided for a universe of 1,150 publicly traded stocks.",0.036364275962114334,0.004866600502282381,0.9587691426277161,neutral,0.03149767592549324
46,2018-10-08 06:31:00,Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance.,0.054108913987874985,0.005191051866859198,0.9407000541687012,neutral,0.04891786351799965
47,2018-10-08 06:31:00,Recommendations and target prices are six-month time horizons.,0.013092893175780773,0.007127966266125441,0.9797791242599487,neutral,0.0059649269096553326
48,2018-10-08 06:31:00,"Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar.",0.044983625411987305,0.5624399185180664,0.3925764560699463,negative,-0.5174562931060791
49,2018-10-08 06:31:00,They're virtually unknown to the general public.,0.035764459520578384,0.0785161554813385,0.885719358921051,neutral,-0.04275169596076012
50,2018-10-08 06:31:00,"Yet today's 220 Zacks Rank #1 ""Strong Buys"" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015.",0.6580293774604797,0.017276067286729813,0.32469451427459717,positive,0.6407533288002014
51,2018-10-08 06:31:00,Its average gain has been a stellar +26% per year.,0.8422174453735352,0.0191669799387455,0.13861553370952606,positive,0.8230504393577576
52,2018-10-08 06:31:00,See these high-potential stocks free >>.,0.12527841329574585,0.05778927728533745,0.8169323205947876,neutral,0.0674891322851181
53,2018-10-08 06:31:00,"Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.01284766010940075,0.009404126554727554,0.9777481555938721,neutral,0.003443533554673195
54,2018-10-08 06:31:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
55,2018-10-08 06:31:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
56,2018-10-08 06:31:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
57,2018-10-08 06:31:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
58,2018-10-08 06:31:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
59,2018-10-08 06:31:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
60,2018-10-08 06:31:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
61,2018-10-08 06:31:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
62,2018-10-08 06:31:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
63,2018-10-08 06:31:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
64,2018-10-08 06:31:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
65,2018-10-08 06:31:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
66,2018-10-08 06:31:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
67,2018-10-08 06:31:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
68,2018-10-08 06:31:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
69,2018-10-08 06:31:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
